Canagliflozin Mitigates Diabetic Cardiomyopathy through Enhanced PINK1-Parkin Mitophagy
Abstract
Share and Cite
Yang, C.; Xiao, C.; Ding, Z.; Zhai, X.; Liu, J.; Yu, M. Canagliflozin Mitigates Diabetic Cardiomyopathy through Enhanced PINK1-Parkin Mitophagy. Int. J. Mol. Sci. 2024, 25, 7008. https://doi.org/10.3390/ijms25137008
Yang C, Xiao C, Ding Z, Zhai X, Liu J, Yu M. Canagliflozin Mitigates Diabetic Cardiomyopathy through Enhanced PINK1-Parkin Mitophagy. International Journal of Molecular Sciences. 2024; 25(13):7008. https://doi.org/10.3390/ijms25137008
Chicago/Turabian StyleYang, Chunru, Cheng Xiao, Zerui Ding, Xiaojun Zhai, Jieying Liu, and Miao Yu. 2024. "Canagliflozin Mitigates Diabetic Cardiomyopathy through Enhanced PINK1-Parkin Mitophagy" International Journal of Molecular Sciences 25, no. 13: 7008. https://doi.org/10.3390/ijms25137008